RSS   Newsletter   Contact   Advertise with us

Appili Therapeutics appoints Kimberly Stephens as CFO

Share on Twitter Share on LinkedIn
Staff Writer | Halifax, NS, Canada | October 4, 2016
Appili TherapeuticsOctober 4, 2016, Halifax, NS, Canada - Appili Therapeutics, an anti-infective pharmaceutical development company, announced that Kimberly Stephens has joined the company as chief financial officer.
Ms. Stephens brings over 15 years of financial management experience in senior financial positions with private and public companies. Most recently, she served as CFO of Immunovaccine Inc. from 2011-2016.

Prior to joining Immunovaccine Inc., Ms. Stephens served as director of finance for the Canadian subsidiary of Germanischer Lloyd. She has also been the director of finance for SolutionInc, and started her career as an audit manager in the assurance and advisory group at PwC.

Ms. Stephens holds a bachelor of commerce degree from Mount Allison University and is a chartered professional accountant (CPA).

She will continue to serve Immunovaccine as Chief Financial Officer through December 2016 while the company conducts its ongoing process of identifying and transitioning her successor.